Apreo Health clinical trials
Apreo Health is the lead sponsor of 3 current clinical trials in our UK, Netherlands, Austria, USA, Germany and Israel registers. 2 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Emphysema.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Apreo Health
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
NCT06891755 · COPD, Emphysema
|
Not applicable | Recruiting | 2025-07 | UK, USA, Germany, Netherlands, Austria, Israel |
|
Xenon MRI to Evaluate Changes to Lung Function Following Bronchoscopic Treatment of Air Trapping in Emphysema
NCT07896902 · ClinicalTrials.gov ↗ · Air Trapping, Emphysema, Hyperinflation
|
Early Phase 1 | Recruiting | 2026-10 | USA |
|
Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema
NCT05949645 · Emphysema or COPD
|
Not applicable | Active, closed | 2023-08 | UK, Netherlands, Austria |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in Apreo Health trials
5 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in UK | 2 | 1 |
| Clinical trials in Netherlands | 2 | 1 |
| Clinical trials in Austria | 2 | 1 |
| Clinical trials in USA | 2 | 2 |
| Clinical trials in Germany | 1 | 1 |
| Clinical trials in Israel | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Emphysema
| Sponsor | Trials |
|---|---|
| Pulmair Medical | 3 |
| Pulmonx Corporation | 2 |
Sponsors with the most current trials registered for this condition.
Questions about Apreo Health trials
How many clinical trials does Apreo Health sponsor?
Apreo Health is the lead sponsor of 3 current trials on ClinicalTrials.gov in our UK, Netherlands, Austria, USA, Germany and Israel registers, as of the registry sync on 28 October 2026. Completed and withdrawn studies are not counted.
Are Apreo Health trials recruiting?
Yes. 2 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 28 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.